Literature DB >> 25978140

BMP-2-induced Neuroforaminal Bone Growth in the Setting of a Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Junyoung Ahn1, Ehsan Tabaraee, Kern Singh.   

Abstract

Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) has become a popular alternative to traditional methods of lumbar decompression and fusion. When compared with the open technique, the minimally invasive approach can result in decreased pain and blood loss as well as a shorter length of hospitalization. However, the narrower working channel through the tubular retractor increases the difficulty of decortication and bone grafting. Therefore, recombinant human bone morphogenetic proteins (rhBMP-2) is often utilized (although this is off-label) to create a more favorable interbody fusion environment. Recently, the use of rhBMP-2 has been associated with excessive bone growth in an MIS-TLIF. If this bone growth compresses the neighboring neural structures, patients may present with either new or recurrent radicular pain. Computed tomographic (CT) imaging can demonstrate heterotopic bone growth extending from the disk space into either the ipsilateral neuroforamen or lateral recess, which may result in the compression of the exiting or traversing root, respectively. The purpose of this article and the accompanying video is to demonstrate a technique for defining and resecting rhBMP-2-induced heterotopic bone growth following a previous MIS-TLIF.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25978140     DOI: 10.1097/BSD.0000000000000282

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  3 in total

1.  An awake, minimally-invasive, fully-endoscopic surgical technique for treating lumbar radiculopathy secondary to heterotopic foraminal bone formation after a minimally invasive transforaminal lumbar interbody fusion with BMP: technical note.

Authors:  Albert Edward Telfeian
Journal:  J Spine Surg       Date:  2018-03

2.  Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery.

Authors:  Arjun S Sebastian; Nathan R Wanderman; Bradford L Currier; Mark A Pichelmann; Vickie M Treder; Jeremy L Fogelson; Michelle J Clarke; Ahmad N Nassr
Journal:  Asian Spine J       Date:  2019-03-15

3.  Image Guidance-Assisted Decompression and Removal of Heterotopic Ossification Following the Use of Recombinant Human Bone Morphogenetic Protein-2 in Transforaminal Lumbar Interbody Fusion.

Authors:  Julie L Chan; Robert A Ravinsky; J Patrick Johnson; Eli M Baron
Journal:  Cureus       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.